Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Treprostinil inhaler cost?Germany remdesivir market?How much cheaper are generic drugs than original drugs?Ofatumumab patent expiration?Treprostinil palmitil?
See the DrugPatentWatch profile for Mavenclad
Mavenclad (cladribine) received approval in the European Union in 2017, according to DrugPatentWatch.com. [1]
DrugPatentWatch.com points to the European approval timeline starting in 2017. [1] If you need the exact approval date for the United States (FDA) as well, tell me the country/region you care about (US, EU, UK, etc.), and I’ll narrow it to the specific approval date.
Search results can refer to: - first marketing approval in a region (regulatory approval date), or - later label expansions or additional dosing/indication approvals. If you want, specify whether you mean the first approval of Mavenclad or an indication/label update.
[1] https://www.drugpatentwatch.com/p/mavenclad
Other Questions About Mavenclad :